The effect of statins on the risk of anti-tuberculosis drug-induced liver injury among patients with active tuberculosis: A cohort study

Background: Tuberculosis (TB) remains prevalent worldwide, and anti-TB drugs are associated with drug-induced liver injury (DILI). Statins have pleiotropic effects which may decrease inflammation and achieve immunomodulation. However, few studies have investigated the pleiotropic effects of statins...

Full description

Bibliographic Details
Published in:	Journal of Microbiology, Immunology and Infection
Main Authors:	Chun-Kai Huang, Jei-Yie Huang, Chin-Hao Chang, Shang-Jie Tsai, Chin-Chung Shu, Hao-Chien Wang, Kuo-Liong Chien
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Subjects:	Anti-tuberculosis drug Drug-induced liver injury Statin Tuberculosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S1684118224000690

Similar Items

DRUG-INDUCED LIVER LESIONS AND THEIR MANAGEMENT IN THE MANIFESTATIONS OF TUBERCULOSIS
by: A. V. Mordyk, et al.
Published: (2015-09-01)

Bilateral Multiple Lower Limb Tuberculous Aneurysms in a Pregnant Woman with Drug-Induced Liver Injury due to Tuberculosis Treatment
by: Farah Almadina, et al.
Published: (2025-09-01)

Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study
by: Conor Duncan Tweed, et al.
Published: (2018-03-01)

Gut microbiota characteristics of Mongolian and Han populations in anti-tuberculosis drug-induced liver injury: a population-based case–control study
by: Jinqi Hao, et al.
Published: (2023-03-01)

DNA methylation microarray-based screening of epigenetically masked genes in patients with anti-tuberculosis drug-induced liver injury
by: LI Yuhong, et al.
Published: (2019-02-01)

Evaluating the derangement of LFTs concerning statin use and probable liver injury among non-cardiac patients, in the light of R ratio.
by: Muhammad Ali Khan, et al.
Published: (2023-10-01)

N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study
by: Fang Cheng, et al.
Published: (2023-08-01)

The Effectiveness of Silymarin in the Prevention of Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Randomized Controlled Clinical Trial
by: Ali Talebi, et al.
Published: (2023-04-01)

Pharmaco-epidemiological, clinical and laboratory characteristics of drug-induced liver injury in tuberculosis
by: M. V. Koroleva
Published: (2016-02-01)

Vitamin C Intake and Anti-Tuberculosis Drugs-Induced Hepatitis in Pulmonary Tuberculosis Patients
by: Hadiati Rabbani, et al.
Published: (2024-09-01)

Clinical Features of Anti-Tuberculosis Drug-Induced Liver Injury and Risk Factors for Severe Cases: A Retrospective Study in China
by: Zhang S, et al.
Published: (2025-04-01)

Latent class analysis of inflammation and drug-induced liver injury phenotypes in older tuberculosis patients: associations with anxiety, depression, and insomnia
by: Dan Lei, et al.
Published: (2025-08-01)

The Patterns of Conversion to Anti-Tuberculosis Drug Resistance in Mycobacterium tuberculosis
by: Moo-Sang Chong, et al.
Published: (2022-06-01)

RISK ASSESSMENT AND MONITORING OF HEPATOTOXIC REACTIONS IN TUBERCULOSIS PATIENTS
by: D. A. IVАNOVА, et al.
Published: (2017-10-01)

SUCCINIC ACID PREPARATIONS IN THE COMBINATION TREATMENT OF PATIENTS WITH TUBERCULOSIS
by: A. V. Mordykh, et al.
Published: (2014-06-01)

Evaluation of Drug-induced Liver Injury and its Relationship with NAT2 Gene Polymorphisms in Tuberculosis Patients
by: Farhang Babamahmoodi, et al.
Published: (2017-08-01)

Resistance Rates of Mycobacterium tuberculosis Complex Isolates to Primary Anti-tuberculosis Drugs: A 5-Year Retrospective Study
by: Sondos A. A. Ibnouf, et al.
Published: (2024-04-01)

The feasibility of using liver function indices and FibroScan in combination to predict the occurrence of anti-tuberculosis drug-induced liver injury in Patients with liver disease
by: Shaoqiang Wu, et al.
Published: (2025-01-01)

Association of T‐Cell Profiles With Disease Severity, Drug‐Induced Liver Injury, and Treatment Completion in Tuberculosis
by: Yifan He, et al.
Published: (2025-08-01)

Interpretable machine learning in predicting drug-induced liver injury among tuberculosis patients: model development and validation study
by: Yue Xiao, et al.
Published: (2024-04-01)

Drug-Induced Liver Injury in Tuberculosis: Mechanisms of Development and Diagnostic Methods
by: D. S. Sukhanov, et al.
Published: (2023-02-01)

Incidence and Clinical Profile of Antituberculosis Treatment-Induced Hepatitis in a Tertiary Care Hospital in Southern India
by: TP Jai Juganya, et al.
Published: (2020-10-01)

Genetic Aspects of Mycobacterium Tuberculosis Resistance to New Anti-Tuberculosis Drugs
by: A. V. Kukurika, et al.
Published: (2023-08-01)

Miliary tuberculosis with cerebral, liver, prostate and retroesophageal involvement
by: Raquel Goncalves, et al.
Published: (2017-01-01)

Splenic granuloma: Melioidosis or Tuberculosis?
by: Fibi Ninan, et al.
Published: (2018-01-01)

DIAGNOSTIC DIFFICULTIES OF THE ISOLATED LIVER TUBERCULOSIS
by: T. V. Serova, et al.
Published: (2016-08-01)

Pharmacological correction of hepatotoxicity induced by anti-tuberculosis drugs
by: D. S. Sukhanov, et al.
Published: (2023-04-01)

Nutritional intervention is promising in alleviating liver injury during tuberculosis treatment: a review
by: Yujin Fu, et al.
Published: (2023-09-01)

Unusual Co-existence of Drug-Susceptible Lung Tuberculosis and Drug-Resistant Pleural Tuberculosis: A Rare Case Presentation of Dual Infection
by: Herikurniawan Herikurniawan, et al.
Published: (2025-07-01)

Effectiveness of Prophylactic Use of Hepatoprotectants for Tuberculosis Drug-Induced Liver Injury: A Population-Based Cohort Analysis Involving 6,743 Chinese Patients
by: Qin Chen, et al.
Published: (2022-04-01)

DRUG RESISTANCE OF STRAINS OF M. TUBERCULOSIS, ISOLATED FROM PULMONARY TUBERCULOSIS PATIENTS IN VLADIMIR REGION IN 2013
by: E. S. Dyuzhik, et al.
Published: (2015-10-01)

Multidrug-resistant tuberculosis in Lithuania – Still a long way ahead
by: Greta Musteikienė, et al.
Published: (2016-01-01)

Cycloserine resistance among drug-resistant tuberculosis cases in Taiwan
by: Sheng-Han Wu, et al.
Published: (2025-07-01)

EXPERIENCE OF USING BEDAQUILINE AND LINEZOLID IN THE INTEGRAL TREATMENT OF THE PULMONARY TUBERCULOSIS PATIENT WITH EXTENSIVE DRUG RESISTANCE OF M. TUBERCULOSIS
by: E. M. Zhukova, et al.
Published: (2016-10-01)

Thalidomide as an adjunctive therapy in complex childhood neuro-tuberculosis: a case report
by: Amulya Veeramachaneni, et al.
Published: (2024-07-01)

Characteristics of tuberculosis patients in the integrated tuberculosis control model in Chongqing, China: a retrospective study
by: Liwen Zhang, et al.
Published: (2020-08-01)

Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches
by: Vinayak Singh, et al.
Published: (2021-09-01)

CYP2E1, GSTM1, and GSTT1 genetic polymorphisms and their associations with susceptibility to antituberculosis drug-induced liver injury in Thai tuberculosis patients
by: Noppadol Chanhom, et al.
Published: (2021-04-01)

The spectrum of primary drug resistance of Mycobacterium tuberculosis in patients with tuberculosis in relation to human immunodeficiency virus status
by: V N Zimina, et al.
Published: (2017-11-01)

Chemotherapeutic Interventions Against Tuberculosis
by: Neeraj Shakya, et al.
Published: (2012-06-01)